CellaVision AB (publ) Interim report for the period 1 January - 30 June 2007

2007-08-24 - English

  •    Net sales for the period were SEK 34.1 million (27.7), an increase of 23 per cent, of which SEK 17.3 million (18.6) in the second quarter.
  •    The operating loss for the period was SEK -3.7 million (-5.0) and for the second quarter SEK -2.8 million (-0.3).
  •    Earnings per share for the period were SEK -0.17 (-0.22).
  •    Cash and cash equivalents amounted to SEK 8.8 million at the end of the period.
  •    The company was listed on First North on 28 May.
  •    A new subsidiary was established in Canada.
  •    Four systems were installed at the Karolinska University Laboratory.
    Significant events after the close of the reporting period
  •    There was a preview of the new application for body fluids in the USA in July.
  •    Johan Wennerholm was employed as Chief Financial Officer.

    CEO's comments
    "Up to and including the second quarter CellaVision has delivered a total of 300 systems to customers, mainly in Europe and North America. The initiative in Canada with our own company has attracted great attention to our products, and the number of identified potential customers exceeds expectations. The new body fluid analysis application also generated great interest when it was shown at the international AACC Annual Meeting and Clinical Lab Expo in San Diego, USA in July," says Yvonne Mårtensson, CEO of CellaVision AB.
    "The company's listing on First North has been completed and was well received. With continued good growth I look forward with confidence to achieving profitability in our core business - the hematology market."
    Yvonne Mårtensson
    CEO CellaVision AB
    For more information, please contact:
    Yvonne Mårtensson, CEO. Phone: 0708 33 77 82, e-mail: yvonne.martensson@cellavision.se
    Johan Wennerholm, CFO. Phone: 0708 33 81 68, e-mail: johan.wennerholm@cellavision.se

    PDF version: Interim report for the period Jan - June 2007

    Subscribe to updates

    It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

    Click here to register

    Information request

    Are you looking for some particular information about our company or our business?

    Click here to get in touch


    ABG Sundal Collier AB
    Sten Gustafsson
    +46 8 566 286 93

    Pareto Securities AB
    Christian Lee
    +46 8 402 52 67


    Access our Student Resources

    To access this resource, please provide the following information about yourself.